Browse > Article
http://dx.doi.org/10.9721/KJFST.2019.51.2.141

Antiangiogenic activity of non-aqueous fraction from Sparassis crispa extract in human umbilical vein endothelial cells  

Han, Jang Mi (Department of Pharmaceutical Engineering & Biotechnology, Sun Moon University)
Gong, So Youn (Department of Pharmaceutical Engineering & Biotechnology, Sun Moon University)
Sohng, Jae Kyung (Department of Pharmaceutical Engineering & Biotechnology, Sun Moon University)
Kang, Yue Jai (Department of Aquatic Life and Medical Sciences, Sun Moon University)
Jung, Hye Jin (Department of Pharmaceutical Engineering & Biotechnology, Sun Moon University)
Publication Information
Korean Journal of Food Science and Technology / v.51, no.2, 2019 , pp. 141-146 More about this Journal
Abstract
Sparassis crispa is an edible mushroom that is distributed in Korea, Japan, Europe, and North America. It exerts various biological activities such as immunopotentiation, anti-diabetic, anti-cancer, and anti-inflammatory effects. Recently, we separated the health functional non-aqueous fraction from the chloroform extract of S. crispa (SCF4). In this study, we evaluated the antiangiogenic activity of SCF4 in human umbilical vein endothelial cells (HUVECs). SCF4 effectively inhibited vascular endothelial growth factor (VEGF)-induced cell growth at concentrations ($5-25{\mu}g/mL$) showing no cytotoxic effects. SCF4 inhibited VEGF-induced invasiveness and tube formation ability, which are in vitro angiogenic features of HUVECs, in a dose-dependent manner. In addition, SCF4 markedly suppressed in vivo angiogenesis of chorioallantoic membrane from growing chick embryos without cytotoxicity. Furthermore, SCF4 downregulated the phosphorylation of VEGFR2, AKT, and ERK1/2, which are major angiogenic signal mediators. These results suggest that SCF4 inhibited angiogenesis by suppressing the VEGFR2 signaling pathways without cytotoxicity.
Keywords
Sparassis crispa; non-aqueous fraction; angiogenesis; HUVECs; VEGFR2 signaling;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Avramis IA, Kwock R, Avramis VI. Taxotere and vincristine inhibit the secretion of the angiogenesis inducing vascular endothelial growth factor (VEGF) by wild-type and drug-resistant human leukemia T-cell lines. Anticancer Res. 21: 2281-2286 (2001)
2 Carmeliet P. Angiogenesis in life, disease and medicine. Nature 438: 932-936 (2005)   DOI
3 Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 407: 249-257 (2000)   DOI
4 Clements MK, Jones CB, Cumming M, Daoud SS. Antiangiogenic potential of camptothecin and topotecan. Cancer Chemoth. Pharm. 44: 411-416 (1999)   DOI
5 Coultas L, Chawengsaksophak K, Rossant J. Endothelial cells and VEGF in vascular development. Nature 438: 937-945 (2005)   DOI
6 de Falco S. Antiangiogenesis therapy: an update after the first decade. Korean J. Intern. Med. 29: 1-11 (2014)   DOI
7 Du J, Xu R, Hu Z, Tian Y, Zhu Y, Gu L, Zhou L. PI3K and ERKinduced Rac1 activation mediates hypoxia-induced HIF-1${\alpha}$ expression in MCF-7 breast cancer cells. PLoS One 6: e25213 (2011)   DOI
8 Fan TP, Yeh JC, Leung KW, Yue PY, Wong RN. Angiogenesis: From plants to blood vessels. Trends Pharmacol. Sci. 27: 297-309 (2006)   DOI
9 Gerber HP, Mc Murtrey A, Kowalski J, Yan M, Keyt BA, Dixit V, Ferrara N. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J. Biol. Chem. 273: 30336-30343 (1998)   DOI
10 Han JM, Kwon HJ, Jung HJ. Tricin, 4',5,7-trihydroxy-3',5'-dimethoxyflavone, exhibits potent antiangiogenic activity in vitro. Int. J. Oncol. 49: 1497-1504 (2016)   DOI
11 Hong KB, Hong SY, Joung EY, Kim BH, Bae SH, Park Y, Suh HJ. Hypocholesterolemic effects of the cauliflower culinary-medicinal mushroom, Sparassis crispa (Higher Basidiomycetes), in dietinduced hypercholesterolemic rats. Int. J. Med. Mushrooms 17: 965-975 (2015)   DOI
12 Han JM, Lee EK, Gong SY, Sohng JK, Kang YJ, Jung HJ. Sparassis crispa exerts anti-inflammatory activity via suppression of TLRmediated NF-${\kappa}$B and MAPK signaling pathways in LPS-induced RAW264.7 macrophage cells. J. Ethnopharmacol. 231: 10-18 (2019)   DOI
13 Han JM, Lim HN, Jung HJ. Hovenia dulcis Thunb. and its active compound ampelopsin inhibit angiogenesis through suppression of VEGFR2 signaling and HIF-$1{\alpha}$ expression. Oncol. Rep. 38: 3430-3438 (2017)   DOI
14 Hicklin DJ, Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J. Clin. Oncol. 23: 1011-1027 (2005)   DOI
15 Hida TH, Kawaminami H, Ishibashi K, Miura NN, Adachi Y, Ohno N. Oral administration of soluble ${\beta}$-glucan preparation from the cauliflower mushroom, Sparassis crispa (Higher Basidiomycetes) modulated cytokine production in mice. Int. J. Med. Mushrooms 15: 525-538 (2013)   DOI
16 Holmes K, Roberts OL, Thomas AM, Cross MJ. Vascular endothelial growth factor receptor-2: Structure, function, intracellular signalling and therapeutic inhibition. Cell. Signal. 19: 2003-2012 (2007)   DOI
17 Jing Y, Liu LZ, Jiang Y, Zhu Y, Guo NL, Bamett J, Rojanasakul Y, Agani F, Jiang BH. Cadmium increases HIF-1 and VEGF expression through ROS, ERK, and AKT signaling pathways and induces malignant transformation of human bronchial epithelial cells. Toxicol. Sci. 125: 10-19 (2012)   DOI
18 Ohno N, Miura NN, Nakajima M, Yadomae T. Antitumor 1,3-betaglucan from cultured fruit body of Sparassis crispa. Biol. Pharm. Bull. 23: 866-872 (2000)   DOI
19 Kim HH, Lee S, Singh TS, Choi JK, Shin TY, Kim SH. Sparassis crispa suppresses mast cell-mediated allergic inflammation: role of calcium, mitogen-activated protein kinase and nuclear factor-Kb. Int. J. Mol. Med. 30: 344-350 (2012)   DOI
20 Kimura T. Natural products and biological activity of the pharmacologically active cauliflower mushroom Sparassis crispa. Biomed. Res. Int. 2013: 982317 (2013)   DOI
21 Rajendran P, Rengarajan T, Thangavel J, Nishigaki Y, Sakthisekaran D, Sethi G. The Vascular Endothelium and Human Diseases. Int. J. Biol. Sci. 9: 1057-1069 (2013)   DOI
22 Shi YH, Wang YX, Bingle L, Gong LH, Heng WJ, Li Y, Fang WG. In vitro study of HIF-1 activation and VEGF release by bFGF in the T47D breast cancer cell line under normotoxic conditions: involvement of PI-3K/Akt and MEK1/ERK pathways. J. Pathol. 205: 530-536 (2005)   DOI
23 Vincent L, Kermani P, Young LM, Cheng J, Zhang F, Shido K, Lam G, Bompais-Vincent H, Zhu Z, Hicklin DJ, Bohlen P, Chaplin DJ, May C, Rafii S. Combretastatin A4 phosphate induces rapid regression of tumor neovessels and growth through interference with vascular endothelial-cadherin signaling. J. Clin. Invest. 115: 2992-3006 (2005)   DOI
24 Yamamoto K., Kimura T. Orally and topically administered Sparassis crispa (Hanabiratake) improved healing of skin wounds in mice with streptozotocin-induced diabetes. Biosci. Biotechnol. Biochem. 77: 1303-1305 (2013)   DOI
25 Yamamoto K, Kimura T, Sugitachi A, Matsuura N. Anti-angiogenic and anti-metastatic effects of beta-1,3-D-glucan purified from Hanabiratake, Sparassis crispa. Biol. Pharm. Bull. 32: 259-263 (2009)   DOI
26 Yoshida M, Hida TH, Takeshita K, Tsuboi M, Kanamori M, Akachi N, Miura NN, Adachi Y, Ohno N. Effect of Sasa veitchii extract on immunostimulating activity of ${\beta}$-glucan (SCG) from culinarymedicinal mushroom Sparassis crispa Wulf.:Fr. (higher Basidiomycetes). Int. J. Med. Mushrooms 14: 537-547 (2012)   DOI